Company:  ACORDA THERAPEUTICS INC (ACOR)
Form Type:  8-K
Filing Date:  12/7/2017 
CIK:  0001008848 
Address:  420 SAW MILL RIVER ROAD 
City, State, Zip:  ARDSLEY, New York 10502 
Telephone:  914-347-4300 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$20.40  
Change: 
-0.65 (-3.09%)  
Trade Time: 
Dec 11  
Market Cap: 
$953.64M
Trade ACOR now with 

© 2017  
Description of Business
We are a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. We market three U.S. Food and Drug Administration (FDA)-approved therapies, including Ampyra (dalfampridine) Extended Release Tablets, 10mg, a treatment to improve walking in patients with multiple sclerosis, or MS, as demonstrated by an increase in walking speed. Ampyra 2016 net revenue was $492.8 million, an increase of approximately 13% over 2015. We also market Zanaflex Capsules and tablets, FDA-approved as short-acting drugs for the management of spasticity, and Qutenza, an FDA-approved dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia, also known as post-shingles pain. We have five Orange Book-listed patents providing protection for Ampyra up to 2027.
Register and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01Other Events
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01Financial Statements and Exhibits
    SIGNATURES
  EXHIBIT 99.1